{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:25:58Z","timestamp":1789575958333,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["MCT-79704"],"award-info":[{"award-number":["MCT-79704"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"WHO-TDR","award":["A30755"],"award-info":[{"award-number":["A30755"]}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["465518\/2014-1"],"award-info":[{"award-number":["465518\/2014-1"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","award":["310679\/2016-8"],"award-info":[{"award-number":["310679\/2016-8"]}],"id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"FAPEMIG","doi-asserted-by":"publisher","award":["PPM-00428-17"],"award-info":[{"award-number":["PPM-00428-17"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ijcard.2018.05.091","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T06:26:53Z","timestamp":1527575213000},"page":"88-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies"],"prefix":"10.1016","volume":"267","author":[{"given":"Andre A.L.","family":"Carmo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos R.","family":"de Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Agudelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoel O.C.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio L.P.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A.","family":"Morillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijcard.2018.05.091_bb0005","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jacc.2009.03.078","article-title":"Indications for implantable cardioverter-defibrillators based on evidence and judgment","volume":"54","author":"Myerburg","year":"2009","journal-title":"J. Am. Coll. Cardiol."},{"issue":"13","key":"10.1016\/j.ijcard.2018.05.091_bb0010","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMoa1608029","article-title":"Defibrillator implantation in patients with nonischemic systolic heart failure","volume":"375","author":"K\u00f8ber","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2018.05.091_bb0015","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1586\/erc.12.111","article-title":"Mortality prediction in Chagas heart disease","volume":"10","author":"Nunes","year":"2012","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"issue":"7","key":"10.1016\/j.ijcard.2018.05.091_bb0020","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1093\/europace\/eut011","article-title":"Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease","volume":"15","author":"Barbosa","year":"2013","journal-title":"Europace"},{"issue":"4","key":"10.1016\/j.ijcard.2018.05.091_bb0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1542-474X.2005.00060.x","article-title":"A Latin American registry of implantable cardioverter defibrillators: the ICD-LABOR study","volume":"10","author":"Dubner","year":"2005","journal-title":"Ann Noninvasive Electrocardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2018.05.091_bb0030","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/europace\/eun325","article-title":"Implantable cardioverter defibrillators and Chagas' disease: results of the ICD Registry Latin America","volume":"11","author":"Muratore","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2018.05.091_bb0035","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1111\/j.1540-8167.2007.01011.x","article-title":"Implantable cardioverter-defibrillators in patients with Chagas heart disease: misperceptions, many questions and the urgent need for a randomized clinical trial","volume":"18","author":"Rassi","year":"2007","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.ijcard.2018.05.091_bb0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/europace\/eup060","article-title":"Implantable cardioverter defibrillator therapy for patients with chronic Chagas' disease: a randomized trial may not be necessary in high-risk patients","volume":"11","author":"Bestetti","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2018.05.091_bb0045","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/europace\/eut123","article-title":"ICDs in Chagas heart disease: the standard treatment for secondary prevention of sudden death","volume":"15","author":"Barbosa","year":"2013","journal-title":"Europace"},{"issue":"9","key":"10.1016\/j.ijcard.2018.05.091_bb0050","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1161\/01.CIR.96.9.2823","article-title":"Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death","volume":"96","author":"Sim","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcard.2018.05.091_bb0055","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.295.2.165","article-title":"Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial","volume":"295","author":"Connolly","year":"2006","journal-title":"JAMA"},{"issue":"7124","key":"10.1016\/j.ijcard.2018.05.091_bb0060","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","article-title":"Bias in location and selection of studies","volume":"316","author":"Egger","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2018.05.091_bb0065","doi-asserted-by":"crossref","unstructured":"Leite LR, Fenelon G, Simoes A, Jr., Silva GG, Friedman PA, de Paola AA. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol. J. Cardiovasc. Electrophysiol. 2003;14(6):567\u201373.","DOI":"10.1046\/j.1540-8167.2003.02278.x"},{"key":"10.1016\/j.ijcard.2018.05.091_bb0070","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/europace\/eut422","article-title":"Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone","volume":"16","author":"Gali","year":"2014","journal-title":"Europace"},{"key":"10.1016\/j.ijcard.2018.05.091_bb0075","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1540-8167.2007.00954.x","article-title":"Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy","volume":"18","author":"Cardinalli-Neto","year":"2007","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"9","key":"10.1016\/j.ijcard.2018.05.091_bb0080","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1540-8159.2011.03108.x","article-title":"Predictors of all-cause 1-year mortality in implantable cardioverter defibrillator patients with chronic Chagas' cardiomyopathy","volume":"34","author":"di Toro","year":"2011","journal-title":"Pacing Clin. Electrophysiol."},{"key":"10.1016\/j.ijcard.2018.05.091_bb0085","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.amjcard.2012.05.040","article-title":"Long-term follow-up of implantable cardioverter-defibrillator for secondary prevention in Chagas' heart disease","volume":"110","author":"Martinelli","year":"2012","journal-title":"Am. J. Cardiol."},{"issue":"1 Pt 2","key":"10.1016\/j.ijcard.2018.05.091_bb0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1540-8159.1997.tb04841.x","article-title":"Implantable cardioverter defibrillators in patients with Chagas' disease: are they different from patients with coronary disease?","volume":"20","author":"Muratore","year":"1997","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"11 Pt 2","key":"10.1016\/j.ijcard.2018.05.091_bb0095","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1111\/j.1540-8159.2000.tb07058.x","article-title":"Probability of occurrence of life-threatening ventricular arrhythmias in Chagas' disease versus non-Chagas' disease","volume":"23","author":"Martinelli Filho","year":"2000","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"1 Pt 2","key":"10.1016\/j.ijcard.2018.05.091_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1540-8159.1999.tb00333.x","article-title":"Time to first shock in implantable cardioverter defibrillator (ICD) patients with Chagas cardiomyopathy","volume":"22","author":"Rabinovich","year":"1999","journal-title":"Pacing Clin. Electrophysiol."},{"issue":"5","key":"10.1016\/j.ijcard.2018.05.091_bb0105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/hc0502.103330","article-title":"Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks","volume":"105","author":"Schron","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ijcard.2018.05.091_bb0110","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.hrthm.2011.07.036","article-title":"Shocks burden and increased mortality in implantable cardioverter-defibrillator patients","volume":"8","author":"Larsen","year":"2011","journal-title":"Heart Rhythm."},{"issue":"4","key":"10.1016\/j.ijcard.2018.05.091_bb0115","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.CIR.93.4.753","article-title":"Incidence and clinical significance of multiple consecutive, appropriate, high-energy discharges in patients with implanted cardioverter-defibrillators","volume":"93","author":"Villacast\u00edn","year":"1996","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ijcard.2018.05.091_bb0120","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.hrthm.2012.08.032","article-title":"Implantable cardioverter-defibrillator shock prevention does not reduce mortality: a systemic review","volume":"9","author":"Ha","year":"2012","journal-title":"Heart Rhythm."},{"issue":"1","key":"10.1016\/j.ijcard.2018.05.091_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1540-8167.2005.00315.x","article-title":"Sudden cardiac death in patients with Chagas heart disease and preserved left ventricular function","volume":"17","author":"Sternick","year":"2006","journal-title":"J. Cardiovasc. Electrophysiol."},{"issue":"24","key":"10.1016\/j.ijcard.2018.05.091_bb0130","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1056\/NEJMoa1211107","article-title":"Reduction in inappropriate therapy and mortality through ICD programming","volume":"367","author":"Moss","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2018.05.091_bb0135","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.jacc.2012.11.007","volume":"61","author":"Epstein","year":"2013","journal-title":"J Am Coll Cardiol."},{"issue":"41","key":"10.1016\/j.ijcard.2018.05.091_bb0140","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.ijcard.2018.05.091_bb0145","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrcardio.2012.108","article-title":"The emerging role of amiodarone and dronedarone in Chagas disease","volume":"9","author":"Benaim","year":"2012","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2018.05.091_bb0150","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1021\/jm050691f","article-title":"Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole","volume":"49","author":"Benaim","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijcard.2018.05.091_bb0155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijcard.2015.04.061","article-title":"Amiodarone and Trypanosoma cruzi parasitemia in patients with Chagas disease","volume":"189","author":"Carmo","year":"2015","journal-title":"Int. J. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2018.05.091_bb0160","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1056\/NEJMoa1507574","article-title":"Randomized trial of Benznidazole for chronic Chagas' cardiomyopathy","volume":"373","author":"Morillo","year":"2015","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318302109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318302109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,7]],"date-time":"2024-07-07T03:19:24Z","timestamp":1720322364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318302109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":32,"alternative-id":["S0167527318302109"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.05.091","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2018.05.091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}